Kittipatarin Christina, Khaled Annette R
Biomolecular Science Center, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32826, USA.
J Immunol Methods. 2009 May 15;344(1):45-57. doi: 10.1016/j.jim.2009.03.001. Epub 2009 Mar 17.
Interleukin-7 (IL-7) increases lymphocyte numbers, a critical feature of immune reconstitution, through mechanisms that are still poorly understood. Part of the problem is that IL-7 is produced in limited amounts by non-lymphoid cells, making in vivo studies of the cytokine's activity a challenge. To overcome this, we developed an in vitro system by which lymphocytes from secondary immune organs could be cultured to produce IL-7 responsive cells. Using this method, we showed that CD8(hi)CD44(hi) T cells accumulate in culture with IL-7 from a population of lymph node or splenic cells. These results were validated when a similar lymphocyte subset was found in mice expressing a constitutively active form of STAT5b, a key transducer of IL-7 signals. Interestingly, IL-7-expanded cells also up regulated the activation marker, CD69. The IL-7-derived CD44(hi)CD69(hi) cells were not generated from naïve cells, but expanded from an existing population, since culture in IL-7 of naïve lymphocytes from OT-1/Rag1(-/-) mice did not produce CD44(hi)CD69(hi) cells. Using the in vitro culture system to study lymphocytes from mice deficient in the apoptotic protein, BIM, we were able to attribute the expansion of CD8(hi)CD44(hi)CD69(hi) T cells to the proliferative and not survival activity of IL-7. The in vitro culture system provides an important new methodology to examine the activities of this essential as well as immunotherapeutic cytokine.
白细胞介素-7(IL-7)通过仍未完全了解的机制增加淋巴细胞数量,这是免疫重建的一个关键特征。部分问题在于非淋巴细胞产生的IL-7数量有限,这使得对该细胞因子活性进行体内研究成为一项挑战。为克服这一问题,我们开发了一种体外系统,通过该系统可以培养来自二级免疫器官的淋巴细胞以产生对IL-7有反应的细胞。使用这种方法,我们发现,来自淋巴结或脾细胞群体的细胞在与IL-7共同培养时,CD8(hi)CD44(hi) T细胞会积累。当在表达组成型活性形式的STAT5b(IL-7信号的关键转导因子)的小鼠中发现类似的淋巴细胞亚群时,这些结果得到了验证。有趣的是,IL-7扩增的细胞还上调了激活标志物CD69。IL-7衍生的CD44(hi)CD69(hi)细胞并非由幼稚细胞产生,而是从现有的群体中扩增而来,因为来自OT-1/Rag1(-/-)小鼠的幼稚淋巴细胞在IL-7中培养不会产生CD44(hi)CD69(hi)细胞。利用体外培养系统研究缺乏凋亡蛋白BIM的小鼠的淋巴细胞,我们能够将CD8(hi)CD44(hi)CD69(hi) T细胞的扩增归因于IL-7的增殖活性而非存活活性。该体外培养系统提供了一种重要的新方法,用于研究这种重要的以及免疫治疗性细胞因子的活性。